Senseonics Holdings Inc (SENS) Stock Analysis

Senseonics Holdings Inc (SENS) is a publicly traded company in the HEALTHCARE sector. It trades at $6.87, carries a market capitalization of $357.07M. This page summarizes the public market data, fundamentals, and frequently asked questions for SENS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE MKT

Key Metrics

Market Sentiment

Senseonics Holdings Inc currently has a Bullish sentiment score of 0.33.

About Senseonics Holdings Inc

Senseonics Holdings, Inc. is a cutting-edge medical technology firm headquartered in Germantown, Maryland, specializing in the development of innovative continuous glucose monitoring (CGM) systems for diabetes management. The company's proprietary CGM solutions provide real-time glucose data and actionable insights, significantly enhancing patient outcomes and quality of life for individuals with diabetes. With its products currently available in the United States, Europe, the Middle East, an...

GNG Research Analysis

GNG Research scores Senseonics Holdings Inc (SENS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SENS.

Frequently Asked Questions

Does SENS pay dividends?

Senseonics Holdings Inc (SENS) does not currently pay a regular dividend.

What is SENS's market cap?

Senseonics Holdings Inc (SENS) has a market capitalization of $357.07M with a current stock price of $6.87.